Sonova (OTCMKTS:SONVY) Hits New 1-Year Low – Here’s What Happened

Sonova Holding (OTCMKTS:SONVY) shares hit a new 52-week low on Monday . The company traded as low as $47.31 and last traded at $47.31, with a volume of 9453 shares changing hands. The stock had previously closed at $48.82.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. BNP Paribas Exane upgraded shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th. Zacks Research raised Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Finally, Royal Bank Of Canada upgraded Sonova to a “moderate buy” rating in a report on Tuesday, November 18th. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Sonova has a consensus rating of “Moderate Buy”.

Sonova Price Performance

The stock’s 50 day moving average price is $52.66 and its 200 day moving average price is $53.61. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 1.24.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.